
Biotron
BIT.AXBiotron Limited Price (BIT.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
902,170,065
(9.9079)%
Community Sentiment
0 votes
↑ 0%
↓ 0%
Description
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $0.003-0.11
- Market Cap 6.32M
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Biotechnology
- ceo: Dr. Michelle Miller BSc., GCertAppFin, MSc., Ph.D.
- IPO Date: January, 23, 2001
- Country: AU
- Currency: AUD
- Headquaters: Sydney, NSW
- Employees: 4
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
